Results 181 to 190 of about 114,065 (338)

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

De-diagnosing chronic lymphocytic leukaemia: An ethical and scientific case for changing diagnostic criteria. [PDF]

Hemasphere
Johnstone P, Allen P, Jimenez-Agrawal P, Agrawal S, Hibbs SP.   +4 more
europepmc   +1 more source

Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial.

The Lancet Oncology, 2018
Jeffrey A Jones, A. Mato, W. Wierda, M. Davids, M. Choi, B. Cheson, R. Furman, N. Lamanna, P. Barr, Lang Zhou, B. Chyla, A. Salem, M. Verdugo, R. Humerickhouse, J. Potluri, S. Coutre, J. Woyach, J. Byrd   +17 more
semanticscholar   +1 more source

An Unusual Presentation of Chronic Lymphocytic Leukaemia [PDF]

Journal of Clinical and Diagnostic Research, 2015
Kavita Paul, Geetika Paul, Harbans Lal Kazal, Nariender Kumar Bairwa   +3 more
doaj   +1 more source

Cryptococcal Infection in a Patient With Chronic Lymphocytic Leukaemia Receiving Acalabrutinib, a Bruton's Tyrosine Kinase Inhibitor: A Case Report. [PDF]

Cureus
Al-Shaker AN, Agarwal A, Saeed MT, Marney Z.   +3 more
europepmc   +1 more source

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: Results for CALGB 10404 (Alliance) [PDF]

, 2018
Fehniger, Todd A.
core   +1 more source

Microenvironmental Influences and Antigenic Stimulation in Chronic Lymphocytic Leukemia [PDF]

, 2009
Hiddemann, Wolfgang, Seiler, Till
core   +1 more source

Chronic granulocytic leukaemia and chronic lymphocytic leukaemia. [PDF]

BMJ, 1974
openaire   +2 more sources

Circulating tumour cells (CTCs) in haematological malignancies: Advances in biology and clinical relevance with a focus on multiple myeloma

British Journal of Haematology, EarlyView.
Spatial heterogeneity limits the sensitivity of bone marrow biopsies, resulting in false‐negative findings. Circulating tumour cells (CTCs) provide a systemic, stratified monitoring approach, using flow cytometry for high tumour burden and EuroFlow or allele‐specific oligonucleotide PCR (ASO‐PCR) for minimal residual disease to enable early relapse ...
Chin‐Mu Hsu, Jui‐Feng Hsu, Jee‐Fu Huang, Yi‐Chang Liu   +3 more
wiley   +1 more source

The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. [PDF]

J Clin Med
Robak T, Iskierka-Jażdżewska E, Puła A, Robak P, Puła B.   +4 more
europepmc   +1 more source